Citigroup’s MediciNova MNOV Stock Holding History

Citigroup’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$839K	Hold	635,715	–	–	﹤0.01%	3579
2026 Q1	$871K	Hold	635,715	–	–	﹤0.01%	3207
2025 Q4	$833K	Buy	635,715 +41,658	+7%	+$57.5K	﹤0.01%	3247
2025 Q3	$749K	Buy	594,057 +2,100	+0.4%	+$2.71K	﹤0.01%	3349
2025 Q2	$775K	Hold	591,957	–	–	﹤0.01%	3339
2025 Q1	$864K	Buy	591,957 +90,000	+18%	+$159K	﹤0.01%	3350
2024 Q4	$1.05M	Buy	501,957 +54,000	+12%	+$105K	﹤0.01%	3325
2024 Q3	$941K	Hold	447,957	–	–	﹤0.01%	3310
2024 Q2	$645K	Hold	447,957	–	–	﹤0.01%	3225
2024 Q1	$650K	Hold	447,957	–	–	﹤0.01%	3380
2023 Q4	$672K	Hold	447,957	–	–	﹤0.01%	3176
2023 Q3	$936K	Sell	447,957 -50,300	-10%	-$117K	﹤0.01%	2579
2023 Q2	$1.15M	Buy	498,257 +50,300	+11%	+$111K	﹤0.01%	2740
2023 Q1	$968K	Hold	447,957	–	–	﹤0.01%	2581
2022 Q4	$918K	Sell	447,957 -2,265	-0.5%	-$5K	﹤0.01%	2684
2022 Q3	$977K	Buy	450,222 +2,265	+0.5%	+$5.24K	﹤0.01%	2748
2022 Q2	$1.13M	Hold	447,957	–	–	﹤0.01%	2556
2022 Q1	$1.2M	Hold	447,957	–	–	﹤0.01%	2793
2021 Q4	$1.2M	Sell	447,957 -2,495	-0.6%	-$8.34K	﹤0.01%	3070
2021 Q3	$1.71M	Sell	450,452 -461	-0.1%	-$1.75K	﹤0.01%	2666
2021 Q2	$1.92M	Sell	450,913 -1,708	-0.4%	-$7.36K	﹤0.01%	2696
2021 Q1	$2.29M	Sell	452,621 -5,359	-1%	-$31.2K	﹤0.01%	2409
2020 Q4	$2.41M	Buy	457,980 +455,562	+18,840%	+$2.61M	﹤0.01%	2685
2020 Q3	$13K	Sell	2,418 -3,536	-59%	-$20.4K	﹤0.01%	6457
2020 Q2	$32K	Sell	5,954 -5,799	-49%	-$30.7K	﹤0.01%	6278
2020 Q1	$44K	Buy	11,753 +3,341	+40%	+$17.4K	﹤0.01%	6082
2019 Q4	$57K	Buy	8,412 +2,883	+52%	+$21.7K	﹤0.01%	6202
2019 Q3	$44K	Sell	5,529 -7,004	-56%	-$62.4K	﹤0.01%	6202
2019 Q2	$121K	Buy	12,533 +1,122	+10%	+$11.8K	﹤0.01%	5696
2019 Q1	$94K	Buy	11,411 +2,651	+30%	+$23.1K	﹤0.01%	5800
2018 Q4	$72K	Sell	8,760 -2,208	-20%	-$22K	﹤0.01%	5935
2018 Q3	$137K	Buy	10,968 +4,789	+78%	+$48.1K	﹤0.01%	5601
2018 Q2	$49K	Sell	6,179 -1,055	-15%	-$10.9K	﹤0.01%	6302
2018 Q1	$74K	Sell	7,234 -2,339	-24%	-$23.3K	﹤0.01%	5873
2017 Q4	$62K	Buy	9,573 +495	+5%	+$3.28K	﹤0.01%	6021
2017 Q3	$58K	Buy	9,078 +4,174	+85%	+$22.2K	﹤0.01%	5917
2017 Q2	$25K	Sell	4,904 -1,009	-17%	-$5.66K	﹤0.01%	6174
2017 Q1	$35K	Sell	5,913 -26,168	-82%	-$158K	﹤0.01%	5935
2016 Q4	$193K	Buy	32,081 +17,221	+116%	+$121K	﹤0.01%	5304
2016 Q3	$111K	Buy	14,860 +11,866	+396%	+$79.9K	﹤0.01%	5136
2016 Q2	$23K	Buy	2,994 +2,494	+499%	+$18K	﹤0.01%	6067
2016 Q1	$4K	Buy	500 +442	+762%	+$2.19K	﹤0.01%	7070
2015 Q4	$0	Buy	+58	New	+$184	﹤0.01%	7744
2014 Q3	–	Sell	-762	Closed	-$2K	–	7202
2014 Q2	$2K	Buy	+762	New	+$1.49K	﹤0.01%	6761

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup's MNOV Position: Q2 2026 in Review

Citigroup held its MediciNova (MNOV) position steady in Q2 2026 at 635,715 shares worth $839K. The position accounts for ﹤0.01% of the portfolio, ranked #3579.

Citigroup first reported a position in MNOV in Q2 2014 and has held it in 44 quarters since. The position peaked at $2.41M in Q4 2020. 28 funds tracked by Wall St. Rank hold MNOV as of Q2 2026.

Citigroup held 635,715 shares of MediciNova worth $839K as of Q2 2026.
Citigroup left its MediciNova share count unchanged in Q2 2026.
MediciNova made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3579 holding.
Citigroup first reported a position in MediciNova in Q2 2014 and has held it in 44 quarters since.
Citigroup's MediciNova position peaked at $2.41M in Q4 2020.
28 funds tracked by Wall St. Rank held MediciNova as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.